Crenezumab (Anti-Amyloid Beta)Crenezumab (Anti-Amyloid Beta)
Move your mouse over image or click to enlarge

Crenezumab (Anti-Amyloid Beta)

Crenezumab (Anti-Amyloid Beta) is a fully humanized immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.
Cat# Size Price Qty Buy
A2764-1mg*25 1mg*25
£4,152.00
A2764-1mg*5 1mg*5
£1,384.00
A2764-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2764

Related Documents